1105662-89-2

Basic information

• Product Name: 3-Azetidineacetic acid, 3-aMino-1-[(1,1-diMethylethoxy)carbonyl]-, Methyl ester
• Synonyms: 3-Azetidineacetic acid, 3-aMino-1-[(1,1-diMethylethoxy)carbonyl]-, Methyl ester;tert-Butyl 3-amino-3-(2-methoxy-2-oxoethyl)azetidine-1-carboxylate
• CAS NO: 1105662-89-2
• Molecular Formula: C₁₁H₂₀N₂O₄
• Molecular Weight: 244.2875
• Mol File: 1105662-89-2.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 313.1±27.0 °C(Predicted)
• Appearance: /
• Density: 1.148±0.06 g/cm3(Predicted)
• PKA: 6.66±0.20(Predicted)
• CAS DataBase Reference: 3-Azetidineacetic acid, 3-aMino-1-[(1,1-diMethylethoxy)carbonyl]-, Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Azetidineacetic acid, 3-aMino-1-[(1,1-diMethylethoxy)carbonyl]-, Methyl ester(1105662-89-2)
• EPA Substance Registry System: 3-Azetidineacetic acid, 3-aMino-1-[(1,1-diMethylethoxy)carbonyl]-, Methyl ester(1105662-89-2)

Safety Data

• Hazardous Substances Data: 1105662-89-2(Hazardous Substances Data)

Upstream product

• 398489-26-4 tert-butyl 3-oxoazetidine-1-carboxylate 
• 1105662-87-0 tert-butyl 3-(2-methoxy-2-oxo-ethylidene)azetidine-1-carboxylate 

Downstream Products

• 1105662-91-6 tert-butyl 3-(3-ethoxy-3-oxopropanamido)-3-(2-methoxy-2-oxoethyl)azetidine-1-carboxylate 

Relevant articles and documents

Furo-3-carboxamide derivatives and methods of use

Compounds of formula (I) and pharmaceutically acceptable salts, esters, amides, or radiolabelled forms thereof, wherein R1, Z1, Z2, and n are as defined in the specification, are useful in treating conditions or disorders prevented by or ameliorated by Tropomysin receptor kinases (Trk). Methods for making the compounds are disclosed. Also disclosed are pharmaceutical compositions of compounds of formula (I), and methods for using such compounds and compositions.

PARTIALLY SATURATED NITROGEN-CONTAINING HETEROCYCLIC COMPOUND

There are provided compounds having a superior PHD2 inhibitory effect that are represented by general formula (I'): (in the above-mentioned general formula (I'), W, Y, R2, R3, R4, and Y4 are as described hereinabove), or pharmaceutically acceptable salts thereof.